DCM
Universal Safety Products, Inc.
There isn't enough reported data to score DCM yet.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
DCM Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Weak |
DCM's revenue, profitability, cash flow and balance sheet are all currently weak.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DCM PE Valuation
DCM has no meaningful PE right now: it lost money over the past year.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
DCM Forward outlook
There aren't enough analyst estimates for DCM to show an outlook.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.05 | -272% |
| Q1 2026 | -$1.04 | -573% |
| Q4 2025 | -$0.08 | +$0.46 |
| Q3 2025 | $0.51 | +$0.61 |
| Q2 2025 | $1.19 | +$1.62 |
| Q1 2025 | $0.22 | +$0.39 |
| Q4 2024 | -$0.54 | -460% |
| Q3 2024 | -$0.10 | -138% |
EOSE has the stronger earnings trend. Trailing diluted EPS is down 272% for DCM versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
DCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $109.6K | -97% |
| Q1 2026 | $240.4K | -96% |
| Q4 2025 | $22.5K | -100% |
| Q3 2025 | $760K | -89% |
| Q2 2025 | $3.8M | -17% |
| Q1 2025 | $6.2M | +29% |
| Q4 2024 | $5.5M | +19% |
| Q3 2024 | $7.2M | +94% |
DCM's revenue has slid since its 2024 peak: $109,559 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -673% | -659 points |
| Q1 2026 | -419% | -435 points |
| Q4 2025 | -9700% | -9685 points |
| Q3 2025 | -122% | -132 points |
| Q2 2025 | -14% | -5.3 points |
| Q1 2025 | 16% | +25 points |
| Q4 2024 | -16% | -18 points |
| Q3 2024 | 9.4% | +14 points |
DCM's operating margin was −673% last quarter, down 659 points from the same quarter a year ago, near the bottom of its range since 2019.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over DCM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE has the edge over DCM on profitability, with a higher operating margin.
DCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$733.2K | -127% |
| Q1 2026 | -$811.4K | -$499.8K |
| Q4 2025 | -$2.6M | -202% |
| Q3 2025 | $1.2M | +$3.3M |
| Q2 2025 | $2.8M | +$4M |
| Q1 2025 | -$311.6K | -182% |
| Q4 2024 | $2.5M | +$3M |
| Q3 2024 | -$2.1M | -541% |
DCM has the edge over EOSE on cash flow, with more consistent year-over-year improvement.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
DCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +27% | +624K shares |
| 1 year | +27% | +624K shares |
| 3 years | +27% | +624K shares |
| 5 years | +27% | +624K shares |
| Available history | +27% | +624K shares |
DCM has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
DCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 4.3x | High |
| Q4 2023 | 4.3x | High |
| Q3 2023 | 1.9x | Healthy |
| Q2 2023 | 2.0x | Healthy |
| Q1 2023 | 1.3x | Healthy |
| Q4 2022 | -0.2x | Net Cash |
| Q3 2022 | -0.5x | Net Cash |
| Q2 2022 | -26.9x | Net Cash |
DCM's net debt is about 4.3 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.5 | Neutral |
| Stochastic | 5.7 | Oversold |
DCM's weekly RSI is 37 (neutral) and its Stochastic is 6 (oversold).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DCM PE vs Industrials Sector
| Metric | DCM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
DCM has no meaningful PE right now: it lost money over the past year.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
DCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.16 | 27% below |
| 20 week MA | $4.32 | 30% below |
| 50 week MA | $5.02 | 40% below |
| 100 week MA | $4.10 | 26% below |
| 200 week MA | $3.05 | 0.7% below |
DCM is in a downtrend: it's below all five of its weekly moving averages, and 0.7% below its 200-week average.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
DCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.61 | $2.91 | +377% |
| 2021 | $2.91 | $3.64 | +25% |
| 2022 | $3.64 | $2.10 | -42% |
| 2023 | $2.10 | $1.66 | -21% |
| 2024 | $1.66 | $2.31 | +39% |
| 2025 | $2.31 | $5.00 | +116% |
| 2026 YTD | $5.00 | $3.03 | -39% |
DCM has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.